Stock FPH FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Fisher & Paykel Healthcare Corporation Limited

Equities

FPH

NZFAPE0001S2

End-of-day quote New Zealand S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
29.5 NZD +3.51% Intraday chart for Fisher & Paykel Healthcare Corporation Limited +4.13% +25.00%
May. 29 Fisher & Paykel Healthcare Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
May. 29 New Zealand Shares Flat; Fisher & Paykel Healthcare's Fiscal 2024 Net Profit Falls MT

Evolution of the average Target Price on Fisher & Paykel Healthcare Corporation Limited

Price target over the last 5 years

History of analyst recommendation changes

52a67649.hwdrq5giX4mxyb48Q7pDAHxG7EQdteTCNRvojfKmHDs.3UkA-8IQHM3i-vFWG-IEVlFztnZy7K33d06M-ovfalTYS1mGtVFo_PSPjg~a70a357464454de7929aa3f02090c485

Analyst Recommendations on Fisher & Paykel Healthcare Corporation Limited

JPMorgan Upgrades Fisher & Paykel Healthcare to Neutral from Underweight; Price Target is NZ$24.00 MT
Morgan Stanley Adjusts Fisher & Paykel Healthcare’s Price Target to NZ$24.12 From NZ$23.12, Keeps at Equalweight MT
Morgan Stanley Adjusts Fisher & Paykel Healthcare’s Price Target to AU$22.19 From AU$21.50, Keeps at Equalweight MT
UBS Adjusts Fisher & Paykel Healthcare's Price Target to NZ$17.70 From NZ$18.40, Keeps at Sell MT
UBS Adjusts Fisher & Paykel Healthcare's Price Target to NZ$18.4 From NZ$21.9, Keeps at Sell MT
Australia shares rise; New Zealand falls as cenbank hikes rate RE
UBS Adjusts Fisher & Paykel Healthcare's Price Target to NZ$21.90 From NZ$23.50, Keeps at Sell MT
Fisher & Paykel Healthcare : F&P Healthcare Raises Guidance as Pandemic Boosts Sales to Hospitals --Update DJ
Fisher & Paykel Healthcare : F&P Healthcare Raises Guidance as Pandemic Boosts Sales to Hospitals DJ
National Australia Bank : Australia shares wobble ahead of cenbank rate decision; NZ falls RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
29.5 NZD
Average target price
26.11 NZD
Spread / Average Target
-11.48%
High Price Target
32.8 NZD
Spread / Highest target
+11.19%
Low Price Target
20.14 NZD
Spread / Lowest Target
-31.73%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Fisher & Paykel Healthcare Corporation Limited

JPMorgan
Morgan Stanley
UBS

Ratings for Fisher & Paykel Healthcare Corporation Limited

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. FPH Stock
  4. Consensus Fisher & Paykel Healthcare Corporation Limited